Metformin Class Action
James H. Brown and Associates is investigating a class action on behalf of individuals who were prescribed certain brands of diabetes medications containing metformin. Certain metformin medications may contain N-nitrosodimethylamine (NDMA) in quantities above the acceptable limit. NDMA is considered a probable carcinogen.
Refer to Health Canada’s Recall and Safety Alerts (healthycanadians.gc.ca) for the most up to date listing of recalled products.
If you or a loved one was prescribed metformin or was diagnosed with cancer after taking metformin, please contact us through the form below.
Helpful Resources
To learn more please visit the articles below:
Global News:Certain metformin drugs recalled due to high levels of carcinogenic contaminant
Government of Canada: Metformin Recall Information
CBC: Regulators in Canada, Europe and U.S. probe diabetes drug metformin for carcinogen NDMA